Johnson and Johnson kicks off final study of single-shot Covid-19 vaccine
Johnson & Johnson last Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify
Read moreJohnson & Johnson last Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify
Read more